Anbio Biotechnology (NNNN) stock
NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$3.65−0.23 (-5.93%)
Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –
Anbio Biotechnology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Anbio Biotechnology's price to book ratio was 5.9× on Nov 11, 2026, against 57.6× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.9× | −68.1 |
| 2025 | Dec 31, 2025 | 74.0× | – |
See a number that looks wrong?